U.S. market Closed. Opens in 3 hours 4 minutes

CLRB | Cellectar Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A33.33K96.31K125.97KN/AN/A12.58K
Cost of Revenue192.38K238.87K227.64K207.93K189.36KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-192.38K-238.87K-227.64K-207.93K-189.36KN/AN/AN/AN/AN/AN/AN/AN/A33.33K96.31K125.97KN/AN/A12.58K
Operating Expenses38.96M28.81M24.13M15.29M14.18M11.66M13.60M9.45M8.55M9.67M11.30M8.75M6.29M5.48M10.26M16.72M20.29M8.93M2.58M
Selling, General & Admin10.75M9.59M6.54M5.15M5.18M4.82M4.14M4.70M3.40M3.70M4.44M3.63M2.69M2.49M2.18M2.19M2.87M2.49M1.44M
Research & Development28.21M19.22M17.59M10.14M9.00M6.84M9.47M4.75M5.16M5.96M6.86M5.12M3.60M3.00M8.08M14.53M17.43M6.44M1.14M
Other Operating Expenses0N/A6.63KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-38.96M-28.81M-24.13M-15.29M-14.18M-13.33M-13.60M-9.45M-8.55M-9.67M-11.30M-8.75M-6.29M-5.45M-10.17M-16.59M-20.29M-8.93M-2.57M
Other Expenses / Income917.15K152.52K8.92K196.18K85.71K-1.61M38.68K3.27M3.06M1.56M522.76K-42.19K-713.89K7.54M-12.11M9.00K7.13K6.00K-427.79K
Before Tax Income-38.04M-28.66M-24.12M-15.09M-14.09M-13.24M-13.56M-6.18M-5.50M-8.11M-10.78M-8.80MN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses60.00K-60.00K-152.20K-337.63K-218.51K-1.55MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-37.98M-28.60M-23.97M-14.76M-13.87M-13.24M-13.56M-6.18M-5.50M-8.11M-10.78M-8.80M-7.44M2.10M-22.27M-16.45M-19.56M-8.29M-3.05M
Interest ExpensesN/A-300.95KN/AN/AN/A29.69K16.61KN/AN/AN/AN/A9.34K430.02KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding12.22M7.06M5.55M1.98M767.51K296.20K140.31K453.66K78.20K45.93K27.95K20.56K11.98K1.48K227.00143.00128.00128.00128.00
Diluted Shares Outstanding12.22M7.06M5.55M1.98M767.51K296.20K140.31K453.66K78.20K45.93K27.95K20.56K11.98K1.48K227.00143.00128.00128.00128.00
EBITDA-38.77M-28.81M-24.13M-15.48M-14.22M-9.96M-12.00M-9.09M-8.19M-9.30M-10.88M-8.26M-5.71M2.13M-22.24M-16.43M-20.28M-8.92M-3.05M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%6,392.07%-23,092.13%-13,046.58%0.00%0.00%-24,238.36%
EBIT-37.92M-28.96M-24.12M-15.09M-14.09M-14.76M-13.55M-6.18M-5.50M-8.11M-10.78M-8.79M-7.01M2.10M-22.27M-16.45M-19.56M-8.29M-3.05M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%6,286.05%-23,125.72%-13,059.99%0.00%0.00%-24,264.14%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙